ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 298

$540K Total Retail Price of All Prescriptions

Rank: 32 out of 298

439 Patients Receiving at Least One Drug in Part D
88% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Dakota
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 618 552 120 1 3
LEVOTHYROXINE SODIUM 492 428 80 2 1
LISINOPRIL 367 295 68 3 4
OMEPRAZOLE 304 285 58 4 2
FUROSEMIDE 297 266 53 5 5
AMLODIPINE BESYLATE 279 226 55 6 6
POTASSIUM CHLORIDE 258 225 57 7 12
METFORMIN HCL 250 191 49 8 11
METOPROLOL SUCCINATE 237 203 42 9 13
WARFARIN SODIUM 210 205* 31 10 7
HYDROCHLOROTHIAZIDE 176 146 34 11 14
TAMSULOSIN HCL 175 161 28 12 21
ATORVASTATIN CALCIUM 165 149 38 13 9
METOPROLOL TARTRATE 160 129 27 14 10
CITALOPRAM HBR 152 137 24 15 19
GABAPENTIN 149 118 24 16 18
CLOPIDOGREL 142 125 26 17 22
LOSARTAN POTASSIUM 140 116 25 18 15
ALENDRONATE SODIUM 133 118 25 19 26
ALLOPURINOL 129 111 22 20 27
CRESTOR 128 114 25 21 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 116* 20 22 33
DONEPEZIL HCL 118 118 12 23 23
ATENOLOL 114 109* 25 24 17
SERTRALINE HCL 112 107* 20 25 20
ESCITALOPRAM OXALATE 100 75 14 26 67
ZOLPIDEM TARTRATE 99 72 13 27 31
PREDNISONE 96 91* 44 28 34
ALPRAZOLAM 94 71 22 B 29 40
ZETIA 76 65 13 30 91
FLUTICASONE PROPIONATE 76 71* 20 30 37
CARVEDILOL 72 72 12 32 24
NAMENDA 71 <11 <11 33 29
FINASTERIDE 67 67 13 34 69
AMITRIPTYLINE HCL 67 <11 <11 R 34 63
DIGOXIN 66 66 11 36 71
TRIAMTERENE-HCTZ 64 49 12 37 51
ADVAIR DISKUS 64 51 12 37 44
GLIPIZIDE 61 56* 12 39 60
FLUOXETINE HCL 60 48 13 40 45
CLONAZEPAM 60 <11 <11 B 40 43
MELOXICAM 60 46 24 40 39
HYDROCODONE-ACETAMINOPHEN 59 44 21 S3 43 8
LANTUS 54 <11 <11 44 73
NEXIUM 51 46* 12 45 41
CYMBALTA 50 <11 <11 46 58
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.